EA201490105A1 - Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности - Google Patents

Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности

Info

Publication number
EA201490105A1
EA201490105A1 EA201490105A EA201490105A EA201490105A1 EA 201490105 A1 EA201490105 A1 EA 201490105A1 EA 201490105 A EA201490105 A EA 201490105A EA 201490105 A EA201490105 A EA 201490105A EA 201490105 A1 EA201490105 A1 EA 201490105A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
methods
kidney damage
prediction
diagnosis
Prior art date
Application number
EA201490105A
Other languages
English (en)
Russian (ru)
Inventor
Джозеф Андерберг
Джефф Грей
Пол Макферсон
Кевин Накамура
Джеймс Патрик Кампф
Original Assignee
Астьют Медикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астьют Медикал, Инк. filed Critical Астьют Медикал, Инк.
Publication of EA201490105A1 publication Critical patent/EA201490105A1/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EA201490105A 2011-07-09 2012-07-05 Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности EA201490105A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161506038P 2011-07-09 2011-07-09
PCT/US2012/045583 WO2013009573A1 (en) 2011-07-09 2012-07-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
EA201490105A1 true EA201490105A1 (ru) 2014-07-30

Family

ID=47506416

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490105A EA201490105A1 (ru) 2011-07-09 2012-07-05 Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности

Country Status (9)

Country Link
US (2) US20140171522A1 (enExample)
EP (1) EP2729803A4 (enExample)
JP (1) JP2014521088A (enExample)
CN (1) CN103858008B (enExample)
AU (1) AU2012282918A1 (enExample)
CA (1) CA2841880A1 (enExample)
EA (1) EA201490105A1 (enExample)
MX (1) MX2014000283A (enExample)
WO (1) WO2013009573A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014120569A1 (en) * 2013-01-25 2014-08-07 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for human epididymis protein-4 (he4)
US10130950B2 (en) 2013-11-27 2018-11-20 Bio-Rad Laboratories, Inc. Microfluidic droplet packing
CN104045453B (zh) * 2014-06-11 2016-08-24 句容市鑫诚果业家庭农场 一种石榴专用有机肥料及其制备方法
CN106536709A (zh) 2014-06-16 2017-03-22 基纽拜奥股份有限公司 尺寸交替的注入到液滴中以促进分选
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
CN104166003B (zh) * 2014-08-06 2016-06-08 中国人民解放军第二军医大学 人附睾蛋白4在制备系统性红斑狼疮性肾病诊断试剂或试剂盒中的应用
WO2016130802A1 (en) * 2015-02-11 2016-08-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TW201827070A (zh) * 2016-12-19 2018-08-01 康鶴生醫科技股份有限公司 合成多肽、含該多肽的組合物、由其產生的抗體及其用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7347300A (en) * 1999-09-02 2001-03-26 Gene Logic, Inc. Modulation of he4 in inflammatory and renal diseases
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20070087387A1 (en) * 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
KR20100015438A (ko) * 2007-03-09 2010-02-12 트리패스 이미징, 인코포레이티드 He4 모노클로날 항체 및 이의 사용 방법
EP2479568B1 (en) * 2007-03-26 2015-01-07 Novartis AG Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
KR20100122495A (ko) * 2008-02-29 2010-11-22 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 급성 신장 장해 및 예후 추정용 바이오마커 및 그 용도
CN102016552A (zh) * 2008-03-05 2011-04-13 神谷来克斯公司 用于分子的高灵敏性检测的方法和组合物
CN102089658A (zh) * 2008-06-04 2011-06-08 普罗迪奥塞斯股份公司 用于体外测试化学物质的发育毒性和胚胎毒性的蛋白生物标志物
NZ610356A (en) * 2008-08-28 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2528799T3 (es) * 2008-11-22 2015-02-12 Astute Medical, Inc. Métodos para el pronóstico de insuficiencia renal aguda
JP5763098B2 (ja) * 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US20120329071A1 (en) * 2010-03-05 2012-12-27 Mark Chance Protein biomarkers and therapeutic targets for renal disorders
EP2646822B1 (en) * 2010-11-29 2017-11-01 Alere San Diego, Inc. Methods for diagnosis and risk prediction in heart failure
WO2013006629A1 (en) * 2011-07-06 2013-01-10 Alere San Diego Inc. Methods and compositions for assigning likelihood of acute kidney injury progression

Also Published As

Publication number Publication date
WO2013009573A1 (en) 2013-01-17
CN103858008B (zh) 2017-03-01
JP2014521088A (ja) 2014-08-25
EP2729803A1 (en) 2014-05-14
AU2012282918A1 (en) 2014-02-06
US20140171522A1 (en) 2014-06-19
EP2729803A4 (en) 2015-08-05
US20160097779A1 (en) 2016-04-07
CN103858008A (zh) 2014-06-11
CA2841880A1 (en) 2013-01-17
MX2014000283A (es) 2014-05-01

Similar Documents

Publication Publication Date Title
EA201490105A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
EA201290629A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
EA201490384A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2011106746A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012174282A3 (en) Biomarker compositions and methods
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013022995A3 (en) Biomarker compositions and methods
WO2013134786A3 (en) Biomarker compositions and methods
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
JP2017524130A5 (enExample)
WO2010022210A3 (en) Diagnosis and monitoring of renal failure using peptide biomarkers
EA201291314A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
NZ592358A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
EP3734280A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1259001A1 (zh) 癌症的预後和诊断方法
MX361731B (es) Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk.
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290192A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX2012001559A (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
NZ594772A (en) Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c
BR112015014232A2 (pt) lesão renal aguda
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови